Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotic Disorders | 39 | 2024 | 195 | 7.640 |
Why?
|
| Schizophrenia | 43 | 2024 | 483 | 6.670 |
Why?
|
| Bipolar Disorder | 26 | 2023 | 387 | 4.690 |
Why?
|
| Antipsychotic Agents | 7 | 2024 | 131 | 1.970 |
Why?
|
| Brain | 23 | 2023 | 2285 | 1.530 |
Why?
|
| Magnetic Resonance Imaging | 37 | 2024 | 3448 | 1.220 |
Why?
|
| Prefrontal Cortex | 7 | 2020 | 134 | 1.050 |
Why?
|
| Facial Recognition | 3 | 2021 | 16 | 1.050 |
Why?
|
| Auditory Cortex | 4 | 2020 | 59 | 1.010 |
Why?
|
| Cognition Disorders | 5 | 2022 | 235 | 0.970 |
Why?
|
| Schizophrenic Psychology | 9 | 2017 | 133 | 0.940 |
Why?
|
| Nerve Net | 8 | 2021 | 374 | 0.860 |
Why?
|
| Hallucinations | 6 | 2024 | 29 | 0.860 |
Why?
|
| Cognitive Dysfunction | 5 | 2024 | 146 | 0.860 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 7 | 2022 | 281 | 0.780 |
Why?
|
| Psychomotor Performance | 7 | 2022 | 496 | 0.780 |
Why?
|
| Saccades | 8 | 2022 | 69 | 0.730 |
Why?
|
| Electroencephalography | 11 | 2024 | 751 | 0.710 |
Why?
|
| Emotions | 9 | 2022 | 349 | 0.700 |
Why?
|
| Brain Mapping | 17 | 2023 | 564 | 0.700 |
Why?
|
| Evoked Potentials, Auditory | 5 | 2022 | 37 | 0.640 |
Why?
|
| Neural Pathways | 9 | 2024 | 319 | 0.640 |
Why?
|
| Visual Perception | 4 | 2014 | 326 | 0.630 |
Why?
|
| Attention | 4 | 2019 | 395 | 0.620 |
Why?
|
| Pediatric Obesity | 1 | 2018 | 26 | 0.620 |
Why?
|
| Child Behavior | 1 | 2018 | 47 | 0.610 |
Why?
|
| Amygdala | 6 | 2021 | 86 | 0.570 |
Why?
|
| Cognition | 11 | 2023 | 580 | 0.560 |
Why?
|
| Humans | 82 | 2024 | 89357 | 0.550 |
Why?
|
| Feeding and Eating Disorders | 1 | 2018 | 180 | 0.540 |
Why?
|
| Neuropsychological Tests | 13 | 2023 | 505 | 0.530 |
Why?
|
| Caudate Nucleus | 2 | 2019 | 15 | 0.520 |
Why?
|
| Feeding Behavior | 1 | 2018 | 327 | 0.520 |
Why?
|
| Adult | 49 | 2024 | 26607 | 0.510 |
Why?
|
| Aggression | 4 | 2022 | 322 | 0.510 |
Why?
|
| Evoked Potentials | 4 | 2021 | 190 | 0.500 |
Why?
|
| Alcoholism | 3 | 2023 | 178 | 0.480 |
Why?
|
| Learning | 2 | 2014 | 285 | 0.470 |
Why?
|
| Young Adult | 25 | 2024 | 6312 | 0.460 |
Why?
|
| Male | 52 | 2024 | 42411 | 0.460 |
Why?
|
| Methamphetamine | 3 | 2019 | 85 | 0.440 |
Why?
|
| Parietal Lobe | 6 | 2023 | 119 | 0.410 |
Why?
|
| Female | 49 | 2024 | 46202 | 0.400 |
Why?
|
| Motor Activity | 1 | 2014 | 327 | 0.390 |
Why?
|
| Central Nervous System Stimulants | 3 | 2019 | 219 | 0.390 |
Why?
|
| Oxytocin | 3 | 2018 | 73 | 0.390 |
Why?
|
| Psychiatric Status Rating Scales | 8 | 2017 | 492 | 0.370 |
Why?
|
| Reaction Time | 4 | 2012 | 310 | 0.360 |
Why?
|
| Eye Movements | 5 | 2017 | 119 | 0.360 |
Why?
|
| Pattern Recognition, Visual | 3 | 2021 | 155 | 0.350 |
Why?
|
| Social Perception | 5 | 2022 | 95 | 0.350 |
Why?
|
| Frontal Lobe | 4 | 2018 | 132 | 0.340 |
Why?
|
| Connectome | 2 | 2021 | 76 | 0.330 |
Why?
|
| Gray Matter | 2 | 2019 | 35 | 0.320 |
Why?
|
| Auditory Pathways | 3 | 2021 | 33 | 0.290 |
Why?
|
| Affective Disorders, Psychotic | 2 | 2019 | 16 | 0.290 |
Why?
|
| Yohimbine | 1 | 2006 | 7 | 0.280 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2006 | 9 | 0.280 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2006 | 31 | 0.280 |
Why?
|
| Oculomotor Nerve | 1 | 2006 | 7 | 0.270 |
Why?
|
| Norepinephrine | 1 | 2006 | 172 | 0.270 |
Why?
|
| Arginine Vasopressin | 2 | 2017 | 44 | 0.260 |
Why?
|
| Speech | 2 | 2018 | 85 | 0.260 |
Why?
|
| Executive Function | 2 | 2018 | 91 | 0.260 |
Why?
|
| Phenotype | 6 | 2021 | 2440 | 0.260 |
Why?
|
| Gyrus Cinguli | 3 | 2019 | 46 | 0.250 |
Why?
|
| Sex Characteristics | 2 | 2018 | 326 | 0.250 |
Why?
|
| Cerebellum | 2 | 2024 | 249 | 0.250 |
Why?
|
| Hyponatremia | 3 | 2010 | 28 | 0.250 |
Why?
|
| Facial Expression | 3 | 2021 | 51 | 0.240 |
Why?
|
| Genome-Wide Association Study | 4 | 2021 | 1671 | 0.240 |
Why?
|
| Photic Stimulation | 5 | 2019 | 501 | 0.230 |
Why?
|
| Pons | 1 | 2024 | 25 | 0.230 |
Why?
|
| Adolescent | 15 | 2024 | 9263 | 0.230 |
Why?
|
| Hippocampus | 4 | 2023 | 447 | 0.220 |
Why?
|
| Self Report | 3 | 2020 | 297 | 0.220 |
Why?
|
| Cannabis | 1 | 2023 | 35 | 0.210 |
Why?
|
| Anger | 3 | 2021 | 80 | 0.210 |
Why?
|
| Lissencephaly | 1 | 2022 | 22 | 0.210 |
Why?
|
| Middle Aged | 23 | 2021 | 25974 | 0.210 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 31 | 0.200 |
Why?
|
| Mental Disorders | 3 | 2017 | 414 | 0.190 |
Why?
|
| Cholinergic Antagonists | 2 | 2021 | 27 | 0.190 |
Why?
|
| Cardiovascular Agents | 1 | 2021 | 54 | 0.190 |
Why?
|
| Ventral Striatum | 1 | 2020 | 5 | 0.190 |
Why?
|
| Neuroimaging | 2 | 2019 | 117 | 0.190 |
Why?
|
| Hostility | 1 | 2021 | 25 | 0.190 |
Why?
|
| Alcohol Drinking | 1 | 2023 | 273 | 0.180 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 82 | 0.180 |
Why?
|
| Reward | 2 | 2020 | 188 | 0.180 |
Why?
|
| Pleasure | 1 | 2019 | 14 | 0.170 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2019 | 15 | 0.170 |
Why?
|
| Lateral Ventricles | 1 | 2019 | 12 | 0.170 |
Why?
|
| Space Perception | 2 | 2014 | 117 | 0.170 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 2019 | 24 | 0.170 |
Why?
|
| Affective Symptoms | 1 | 2019 | 50 | 0.170 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 2366 | 0.170 |
Why?
|
| Gamma Rhythm | 1 | 2019 | 14 | 0.170 |
Why?
|
| Thalamus | 2 | 2018 | 134 | 0.170 |
Why?
|
| Neostriatum | 1 | 2019 | 26 | 0.170 |
Why?
|
| Beta Rhythm | 1 | 2019 | 19 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2020 | 871 | 0.160 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 121 | 0.160 |
Why?
|
| Language | 1 | 2020 | 154 | 0.160 |
Why?
|
| Neurophysins | 1 | 2018 | 4 | 0.160 |
Why?
|
| Vasopressins | 1 | 2018 | 50 | 0.160 |
Why?
|
| Nucleus Accumbens | 1 | 2019 | 113 | 0.150 |
Why?
|
| Child | 5 | 2023 | 7174 | 0.150 |
Why?
|
| Food | 1 | 2018 | 90 | 0.150 |
Why?
|
| Protein Precursors | 1 | 2018 | 140 | 0.150 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2018 | 27 | 0.150 |
Why?
|
| Endophenotypes | 3 | 2022 | 17 | 0.150 |
Why?
|
| Visual Cortex | 2 | 2019 | 255 | 0.150 |
Why?
|
| Twins | 1 | 2017 | 65 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2020 | 2401 | 0.140 |
Why?
|
| Functional Laterality | 2 | 2009 | 200 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 362 | 0.140 |
Why?
|
| Cues | 1 | 2018 | 174 | 0.140 |
Why?
|
| Perforant Pathway | 1 | 2016 | 6 | 0.140 |
Why?
|
| Emotional Intelligence | 1 | 2016 | 22 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2018 | 1242 | 0.130 |
Why?
|
| Citalopram | 1 | 2015 | 20 | 0.130 |
Why?
|
| White Matter | 1 | 2016 | 84 | 0.130 |
Why?
|
| Delusions | 1 | 2014 | 11 | 0.120 |
Why?
|
| Healthy Volunteers | 3 | 2021 | 146 | 0.120 |
Why?
|
| Genotype | 4 | 2020 | 1849 | 0.120 |
Why?
|
| Family | 4 | 2021 | 325 | 0.110 |
Why?
|
| Social Behavior | 1 | 2016 | 299 | 0.110 |
Why?
|
| Third Ventricle | 2 | 2010 | 13 | 0.110 |
Why?
|
| Thirst | 2 | 2010 | 19 | 0.110 |
Why?
|
| Internal Capsule | 1 | 2012 | 9 | 0.100 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2012 | 3 | 0.100 |
Why?
|
| Visual Fields | 2 | 2010 | 98 | 0.100 |
Why?
|
| Behavior Control | 2 | 2023 | 4 | 0.100 |
Why?
|
| Brain Waves | 1 | 2012 | 32 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 1714 | 0.100 |
Why?
|
| Depressive Disorder | 1 | 2012 | 221 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 2340 | 0.090 |
Why?
|
| Polyuria | 1 | 2010 | 7 | 0.090 |
Why?
|
| Biomarkers | 3 | 2024 | 1767 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2017 | 1374 | 0.090 |
Why?
|
| Research Design | 1 | 2014 | 599 | 0.090 |
Why?
|
| Motion Perception | 1 | 2011 | 106 | 0.090 |
Why?
|
| Auditory Perception | 3 | 2019 | 97 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 1840 | 0.090 |
Why?
|
| Electric Injuries | 1 | 2009 | 20 | 0.090 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 3666 | 0.090 |
Why?
|
| Ethanol | 2 | 2023 | 250 | 0.090 |
Why?
|
| Anisotropy | 3 | 2016 | 63 | 0.080 |
Why?
|
| Intelligence | 1 | 2009 | 71 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 2008 | 67 | 0.080 |
Why?
|
| Memory | 2 | 2009 | 220 | 0.070 |
Why?
|
| Rest | 2 | 2018 | 49 | 0.070 |
Why?
|
| Inflammation | 2 | 2023 | 972 | 0.070 |
Why?
|
| Water Intoxication | 1 | 2007 | 3 | 0.070 |
Why?
|
| Acoustic Stimulation | 2 | 2021 | 127 | 0.070 |
Why?
|
| Memory Disorders | 2 | 2021 | 69 | 0.070 |
Why?
|
| Atrophy | 1 | 2007 | 120 | 0.070 |
Why?
|
| Fixation, Ocular | 1 | 2006 | 48 | 0.070 |
Why?
|
| Geniculate Bodies | 1 | 2006 | 140 | 0.070 |
Why?
|
| Interview, Psychological | 2 | 2017 | 69 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2006 | 202 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 228 | 0.060 |
Why?
|
| Somatosensory Cortex | 1 | 2007 | 135 | 0.060 |
Why?
|
| Temporal Lobe | 2 | 2019 | 176 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2006 | 219 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2016 | 71 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 1237 | 0.060 |
Why?
|
| Thinking | 1 | 2023 | 35 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1597 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2019 | 1719 | 0.050 |
Why?
|
| Speech Perception | 2 | 2014 | 71 | 0.050 |
Why?
|
| Individuality | 1 | 2023 | 110 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1942 | 0.050 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 46 | 0.050 |
Why?
|
| Psychological Techniques | 1 | 2021 | 3 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2022 | 75 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 52 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2014 | 8241 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2022 | 371 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2021 | 82 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2022 | 202 | 0.050 |
Why?
|
| Corpus Striatum | 2 | 2012 | 88 | 0.050 |
Why?
|
| Rats | 1 | 2006 | 4041 | 0.040 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2020 | 69 | 0.040 |
Why?
|
| Acoustics | 1 | 2019 | 51 | 0.040 |
Why?
|
| Reflex, Startle | 1 | 2019 | 32 | 0.040 |
Why?
|
| Sample Size | 1 | 2020 | 128 | 0.040 |
Why?
|
| Putamen | 1 | 2019 | 13 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2020 | 87 | 0.040 |
Why?
|
| Functional Neuroimaging | 1 | 2019 | 31 | 0.040 |
Why?
|
| Memory, Short-Term | 1 | 2021 | 227 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1072 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 685 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2022 | 589 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2017 | 119 | 0.040 |
Why?
|
| Nasal Provocation Tests | 1 | 2017 | 129 | 0.040 |
Why?
|
| Happiness | 1 | 2016 | 12 | 0.030 |
Why?
|
| Animals | 3 | 2020 | 27371 | 0.030 |
Why?
|
| Borderline Personality Disorder | 1 | 2016 | 34 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1135 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 306 | 0.030 |
Why?
|
| Heart Rate | 1 | 2018 | 495 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 1723 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 421 | 0.030 |
Why?
|
| Personality | 1 | 2016 | 134 | 0.030 |
Why?
|
| Chlorpromazine | 1 | 2014 | 14 | 0.030 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2014 | 22 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 114 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2018 | 900 | 0.030 |
Why?
|
| Hearing | 1 | 2014 | 57 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2014 | 158 | 0.030 |
Why?
|
| Research | 1 | 2014 | 252 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 4289 | 0.030 |
Why?
|
| Psychometrics | 1 | 2014 | 330 | 0.030 |
Why?
|
| Affect | 1 | 2015 | 387 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 67 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 899 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2012 | 125 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 598 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 160 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 312 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 657 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2010 | 36 | 0.020 |
Why?
|
| Mutation | 1 | 2022 | 4143 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2872 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2010 | 51 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 234 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 2010 | 87 | 0.020 |
Why?
|
| Ocular Motility Disorders | 1 | 2009 | 18 | 0.020 |
Why?
|
| Organ Size | 1 | 2010 | 371 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2009 | 29 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 302 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2009 | 87 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 2009 | 63 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 299 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2009 | 140 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2624 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1862 | 0.020 |
Why?
|
| Motor Cortex | 1 | 2009 | 199 | 0.020 |
Why?
|
| Drinking | 1 | 2007 | 33 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2008 | 146 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2007 | 79 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5499 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 5338 | 0.010 |
Why?
|
| United States | 1 | 2014 | 6989 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 19165 | 0.010 |
Why?
|